Federated Hermes’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.7M Sell
127,058
-13,192
-9% -$3.18M 0.06% 348
2025
Q1
$34.2M Buy
140,250
+2,689
+2% +$655K 0.07% 305
2024
Q4
$45.2M Buy
137,561
+16,338
+13% +$5.37M 0.1% 256
2024
Q3
$40.6M Buy
121,223
+26,787
+28% +$8.96M 0.09% 273
2024
Q2
$25.8M Buy
94,436
+4,253
+5% +$1.16M 0.06% 342
2024
Q1
$31.2M Buy
90,183
+10,693
+13% +$3.7M 0.07% 319
2023
Q4
$25.7M Buy
79,490
+17,762
+29% +$5.74M 0.06% 335
2023
Q3
$22.1M Buy
61,728
+15,871
+35% +$5.69M 0.06% 345
2023
Q2
$17.4M Sell
45,857
-2,343
-5% -$888K 0.04% 420
2023
Q1
$23.1M Buy
48,200
+10,661
+28% +$5.11M 0.06% 351
2022
Q4
$15.8M Sell
37,539
-4,178
-10% -$1.76M 0.04% 432
2022
Q3
$17.4M Sell
41,717
-2,272
-5% -$948K 0.05% 417
2022
Q2
$21.8M Buy
43,989
+7,318
+20% +$3.62M 0.06% 369
2022
Q1
$20.7M Sell
36,671
-18,351
-33% -$10.3M 0.05% 432
2021
Q4
$41.6M Buy
55,022
+978
+2% +$739K 0.08% 310
2021
Q3
$40.3M Sell
54,044
-732
-1% -$546K 0.08% 329
2021
Q2
$35.3M Sell
54,776
-15,303
-22% -$9.86M 0.07% 352
2021
Q1
$40M Sell
70,079
-3,736
-5% -$2.13M 0.08% 323
2020
Q4
$43M Sell
73,815
-2,706
-4% -$1.58M 0.09% 282
2020
Q3
$39.4M Sell
76,521
-8,256
-10% -$4.26M 0.09% 249
2020
Q2
$38.3M Sell
84,777
-47,755
-36% -$21.6M 0.09% 251
2020
Q1
$46.5M Sell
132,532
-19,631
-13% -$6.88M 0.14% 167
2019
Q4
$56.3M Sell
152,163
-25,266
-14% -$9.35M 0.13% 194
2019
Q3
$59M Sell
177,429
-4,212
-2% -$1.4M 0.15% 164
2019
Q2
$56.8M Sell
181,641
-3,995
-2% -$1.25M 0.14% 168
2019
Q1
$56.7M Sell
185,636
-21,904
-11% -$6.7M 0.14% 158
2018
Q4
$48.2M Sell
207,540
-30,022
-13% -$6.97M 0.13% 163
2018
Q3
$74.4M Buy
237,562
+226,667
+2,080% +$70.9M 0.17% 128
2018
Q2
$3.14M Buy
10,895
+2,930
+37% +$845K 0.01% 834
2018
Q1
$1.99M Sell
7,965
-119
-1% -$29.8K 0.01% 959
2017
Q4
$1.93M Sell
8,084
-1,190
-13% -$284K 0.01% 948
2017
Q3
$2.06M Sell
9,274
-512
-5% -$114K 0.01% 903
2017
Q2
$2.22M Sell
9,786
-667
-6% -$151K 0.01% 859
2017
Q1
$2.08M Buy
10,453
+1,833
+21% +$365K 0.01% 891
2016
Q4
$1.57M Sell
8,620
-3,185
-27% -$580K ﹤0.01% 959
2016
Q3
$1.93M Buy
11,805
+2,991
+34% +$490K 0.01% 858
2016
Q2
$1.26M Sell
8,814
-2,062
-19% -$295K ﹤0.01% 1022
2016
Q1
$1.49M Sell
10,876
-7,334
-40% -$1M ﹤0.01% 959
2015
Q4
$2.53M Sell
18,210
-3,788
-17% -$525K 0.01% 771
2015
Q3
$2.96M Buy
21,998
+4,115
+23% +$553K 0.01% 721
2015
Q2
$2.69M Buy
17,883
+898
+5% +$135K 0.01% 807
2015
Q1
$2.3M Buy
16,985
+2,564
+18% +$347K 0.01% 916
2014
Q4
$1.74M Sell
14,421
-7,057
-33% -$851K 0.01% 1005
2014
Q3
$2.44M Buy
21,478
+983
+5% +$111K 0.01% 888
2014
Q2
$2.45M Buy
20,495
+5,510
+37% +$659K 0.01% 868
2014
Q1
$1.92M Sell
14,985
-7,800
-34% -$999K 0.01% 964
2013
Q4
$2.82M Sell
22,785
-1,037
-4% -$128K 0.01% 804
2013
Q3
$2.8M Buy
23,822
+11,304
+90% +$1.33M 0.01% 791
2013
Q2
$1.41M Buy
+12,518
New +$1.41M 0.01% 1001